TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1064190
log Bayes Factor = 138.093
Chromosome 6   position 31,075,115  (GRCh37) Explore rs1064190 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
L40 Psoriasis
0.999 0.001 0.000
E07 Other disorders of thyroid
0.000 0.002 0.998
E07.9 Disorder of thyroid, unspecified
0.000 0.003 0.997
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.005 0.995
L40.5 Arthropathic psoriasis
0.988 0.012 0.000
L40.0 Psoriasis vulgaris
0.985 0.015 0.000
E83.1 Disorders of iron metabolism
0.984 0.016 0.000
C61 Malignant neoplasm of prostate
0.939 0.061 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.152 0.848
L40.4 Guttate psoriasis
0.817 0.182 0.000
E03.8 Other specified hypothyroidism
0.000 0.197 0.803
L40.3 Pustulosis palmaris et plantaris
0.791 0.209 0.000
K90 Intestinal malabsorption
0.000 0.231 0.769
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.242 0.758
E06 Thyroiditis
0.000 0.242 0.758
L40.1 Generalised pustular psoriasis
0.738 0.262 0.000
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
L40.2 Acrodermatitis continua
0.716 0.284 0.000
E07.1 Dyshormogenetic goitre
0.000 0.284 0.716
E07.0 Hypersecretion of calcitonin
0.000 0.284 0.716
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.292 0.708
E07.8 Other specified disorders of thyroid
0.000 0.299 0.701
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.305 0.695
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.328 0.672
E05.8 Other thyrotoxicosis
0.000 0.338 0.662
L40.8 Other psoriasis
0.648 0.352 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.360 0.640
E06.3 Autoimmune thyroiditis
0.000 0.369 0.631
E06.5 Other chronic thyroiditis
0.000 0.392 0.608
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.393 0.607
E03.1 Congenital hypothyroidism without goitre
0.000 0.398 0.602
K90.8 Other intestinal malabsorption
0.000 0.422 0.578
M35.0 Sicca syndrome [Sjogren]
0.000 0.440 0.560
K90.3 Pancreatic steatorrhoea
0.000 0.449 0.551
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.449 0.551
K90.1 Tropical sprue
0.000 0.449 0.551
E06.4 Drug-induced thyroiditis
0.000 0.456 0.544
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.456 0.544
E06.0 Acute thyroiditis
0.000 0.456 0.544
E06.1 Subacute thyroiditis
0.000 0.471 0.529
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E06.9 Thyroiditis, unspecified
0.000 0.633 0.367
C60-C63 Malignant neoplasms of male genital organs
0.325 0.675 0.000
E10.9 Without complications
0.000 0.726 0.274
E10 Insulin-dependent diabetes mellitus
0.000 0.738 0.262
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.741 0.259
L40-L45 Papulosquamous disorders
0.255 0.745 0.000
C60 Malignant neoplasm of penis
0.253 0.747 0.000
E10-E14 Diabetes mellitus
0.000 0.747 0.253
E10.3 With ophthalmic complications
0.000 0.756 0.244
M35 Other systemic involvement of connective tissue
0.000 0.768 0.232
E10.2 With renal complications
0.000 0.775 0.225
C63 Malignant neoplasm of other and unspecified male genital organs
0.225 0.775 0.000
L41 Parapsoriasis
0.203 0.796 0.000
C60.9 Penis, unspecified
0.198 0.802 0.000
E20-E35 Disorders of other endocrine glands
0.000 0.802 0.198
C60.1 Glans penis
0.194 0.806 0.000
M35.7 Hypermobility syndrome
0.000 0.807 0.193
E28 Ovarian dysfunction
0.000 0.809 0.191
E10.7 With multiple complications
0.000 0.811 0.189
E10.0 With coma
0.000 0.816 0.184
L45 Papulosquamous disorders in diseases classified elsewhere
0.183 0.817 0.000
L44 Other papulosquamous disorders
0.182 0.818 0.000
C60.8 Overlapping lesion of penis
0.182 0.818 0.000
C60.2 Body of penis
0.182 0.818 0.000
E12 Malnutrition-related diabetes mellitus
0.000 0.818 0.182
E28.3 Primary ovarian failure
0.000 0.819 0.181
E10.4 With neurological complications
0.000 0.820 0.180
C62 Malignant neoplasm of testis
0.178 0.822 0.000
M35.1 Other overlap syndromes
0.000 0.822 0.178
M35.8 Other specified systemic involvement of connective tissue
0.000 0.822 0.178
M35.2 Behcet's disease
0.000 0.825 0.174
E14 Unspecified diabetes mellitus
0.000 0.826 0.174
C60.0 Prepuce
0.173 0.827 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.828 0.172
E23 Hypofunction and other disorders of pituitary gland
0.000 0.829 0.171
C83.3 Large cell (diffuse)
0.000 0.830 0.170
H00.1 Chalazion
0.169 0.831 0.000
E40-E46 Malnutrition
0.000 0.831 0.169
E24 Cushing's syndrome
0.000 0.833 0.167
L41.1 Pityriasis lichenoides chronica
0.167 0.833 0.000
M35.9 Systemic involvement of connective tissue, unspecified
0.000 0.834 0.166
M35.6 Relapsing panniculitis [Weber-Christian]
0.000 0.834 0.166
M35.5 Multifocal fibrosclerosis
0.000 0.834 0.166
M35.4 Diffuse (eosinophilic) fasciitis
0.000 0.834 0.166
E28.2 Polycystic ovarian syndrome
0.000 0.837 0.163
L42 Pityriasis rosea
0.163 0.837 0.000
C63.9 Male genital organ, unspecified
0.161 0.839 0.000
C63.8 Overlapping lesion of male genital organs
0.161 0.839 0.000
C63.7 Other specified male genital organs
0.161 0.839 0.000
C63.1 Spermatic cord
0.161 0.839 0.000
C63.0 Epididymis
0.161 0.839 0.000
E10.8 With unspecified complications
0.000 0.841 0.159
E23.2 Diabetes insipidus
0.000 0.841 0.159
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.844 0.156
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.844 0.156
E10.6 With other specified complications
0.000 0.844 0.155
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.845 0.155
C63.2 Scrotum
0.153 0.847 0.000
E13 Other specified diabetes mellitus
0.000 0.847 0.153
E14.3 With ophthalmic complications
0.000 0.847 0.153
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.848 0.152
C85.1 B-cell lymphoma, unspecified
0.000 0.849 0.151
E24.2 Drug-induced Cushing's syndrome
0.000 0.851 0.149
C81 Hodgkin's disease
0.000 0.851 0.149
L41.9 Parapsoriasis, unspecified
0.146 0.854 0.000
L41.8 Other parapsoriasis
0.146 0.854 0.000
L41.5 Retiform parapsoriasis
0.146 0.854 0.000
L41.4 Large plaque parapsoriasis
0.146 0.854 0.000
L41.3 Small plaque parapsoriasis
0.146 0.854 0.000
L41.2 Lymphomatoid papulosis
0.146 0.854 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.146 0.854 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.854 0.146
E31 Polyglandular dysfunction
0.000 0.857 0.143
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.858 0.142
E32 Diseases of thymus
0.000 0.858 0.142
E30 Disorders of puberty, not elsewhere classified
0.000 0.858 0.142
C81.9 Hodgkin's disease, unspecified
0.000 0.861 0.139
E10.1 With ketoacidosis
0.000 0.862 0.138
E14.5 With peripheral circulatory complications
0.000 0.862 0.138
E28.9 Ovarian dysfunction, unspecified
0.000 0.863 0.137
E28.8 Other ovarian dysfunction
0.000 0.863 0.137
E28.1 Androgen excess
0.000 0.863 0.137
E28.0 Oestrogen excess
0.000 0.863 0.137
E23.6 Other disorders of pituitary gland
0.000 0.866 0.134
E23.7 Disorder of pituitary gland, unspecified
0.000 0.866 0.134
E10.5 With peripheral circulatory complications
0.000 0.867 0.133
L44.9 Papulosquamous disorder, unspecified
0.131 0.869 0.000
L44.8 Other specified papulosquamous disorders
0.131 0.869 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.131 0.869 0.000
L44.3 Lichen ruber moniliformis
0.131 0.869 0.000
L44.2 Lichen striatus
0.131 0.869 0.000
L44.1 Lichen nitidus
0.131 0.869 0.000
L44.0 Pityriasis rubra pilaris
0.130 0.869 0.000
E12.9 Without complications
0.000 0.869 0.130
E12.8 With unspecified complications
0.000 0.869 0.130
E12.7 With multiple complications
0.000 0.869 0.130
E12.6 With other specified complications
0.000 0.869 0.130
E12.5 With peripheral circulatory complications
0.000 0.869 0.130
E12.4 With neurological complications
0.000 0.869 0.130
E12.3 With ophthalmic complications
0.000 0.869 0.130
E12.2 With renal complications
0.000 0.869 0.130
E12.1 With ketoacidosis
0.000 0.869 0.130
E12.0 With coma
0.000 0.869 0.130
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.870 0.130
E20 Hypoparathyroidism
0.000 0.870 0.130
E21.3 Hyperparathyroidism, unspecified
0.000 0.871 0.129
C62.0 Undescended testis
0.128 0.872 0.000
E14.1 With ketoacidosis
0.000 0.872 0.127
E14.8 With unspecified complications
0.000 0.873 0.127
E26 Hyperaldosteronism
0.000 0.873 0.127
C83.7 Burkitt's tumour
0.000 0.874 0.126
C81.2 Mixed cellularity
0.000 0.875 0.125
C62.1 Descended testis
0.125 0.875 0.000
E14.7 With multiple complications
0.000 0.875 0.125
E14.0 With coma
0.000 0.875 0.125
E25 Adrenogenital disorders
0.000 0.876 0.124
E15 Nondiabetic hypoglycaemic coma
0.000 0.876 0.123
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.877 0.123
E23.1 Drug-induced hypopituitarism
0.000 0.877 0.123
E14.6 With other specified complications
0.000 0.877 0.123
E24.0 Pituitary-dependent Cushing's disease
0.000 0.877 0.123
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.879 0.121
E45 Retarded development following protein-energy malnutrition
0.000 0.879 0.121
E43 Unspecified severe protein-energy malnutrition
0.000 0.879 0.121
E42 Marasmic kwashiorkor
0.000 0.879 0.121
E41 Nutritional marasmus
0.000 0.879 0.121
E40 Kwashiorkor
0.000 0.879 0.121
C81.1 Nodular sclerosis
0.000 0.879 0.121
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.880 0.120
E24.3 Ectopic ACTH syndrome
0.000 0.880 0.120
E24.1 Nelson's syndrome
0.000 0.880 0.120
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified
0.000 0.880 0.119
E14.2 Withrenal complications
0.000 0.880 0.119
E50-E64 Other nutritional deficiencies
0.000 0.881 0.119
E24.8 Other Cushing's syndrome
0.000 0.883 0.117
C81.0 Lymphocytic predominance
0.000 0.883 0.117
C83.1 Small cleaved cell (diffuse)
0.000 0.884 0.116
E13.3 With ophthalmic complications
0.000 0.885 0.115
E29 Testicular dysfunction
0.000 0.885 0.115
E14.4 With neurological complications
0.000 0.885 0.115
C85.0 Lymphosarcoma
0.000 0.888 0.112
C83.6 Undifferentiated (diffuse)
0.000 0.888 0.112
C83.4 Immunoblastic (diffuse)
0.000 0.888 0.112
C83.2 Mixed small and large cell (diffuse)
0.000 0.888 0.112
E24.9 Cushing's syndrome, unspecified
0.000 0.890 0.110
E13.8 With unspecified complications
0.000 0.890 0.110
E13.7 With multiple complications
0.000 0.890 0.110
E13.6 With other specified complications
0.000 0.890 0.110
E13.5 With peripheral circulatory complications
0.000 0.890 0.110
E13.4 With neurological complications
0.000 0.890 0.110
E13.2 With renal complications
0.000 0.890 0.110
E13.1 With ketoacidosis
0.000 0.890 0.110
E13.0 With coma
0.000 0.890 0.110
E16 Other disorders of pancreatic internal secretion
0.000 0.891 0.109
C86 Other specified types of T/NK-cell lymphoma
0.000 0.891 0.109
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.891 0.109
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.891 0.109
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.891 0.109
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.892 0.108
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.892 0.108
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.893 0.107
C81.3 Lymphocytic depletion
0.000 0.893 0.107
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.893 0.107
C92 Myeloid leukaemia
0.000 0.893 0.107
C88 Malignant immunoproliferative diseases
0.000 0.894 0.106
C83.5 Lymphoblastic (diffuse)
0.000 0.894 0.105
E21.2 Other hyperparathyroidism
0.000 0.895 0.105
C93 Monocytic leukaemia
0.000 0.895 0.105
C95 Leukaemia of unspecified cell type
0.000 0.896 0.104
E31.0 Autoimmune polyglandular failure
0.000 0.896 0.104
C81.7 Other Hodgkin's disease
0.000 0.896 0.104
E46 Unspecified protein-energy malnutrition
0.000 0.896 0.104
C92.1 Chronic myeloid leukaemia
0.000 0.897 0.103
E31.9 Polyglandular dysfunction, unspecified
0.000 0.897 0.103
E31.8 Other polyglandular dysfunction
0.000 0.897 0.103
E31.1 Polyglandular hyperfunction
0.000 0.897 0.103
K60.2 Anal fissure, unspecified
0.000 0.897 0.103
E30.9 Disorder of puberty, unspecified
0.000 0.898 0.102
E30.8 Other disorders of puberty
0.000 0.898 0.102
E30.1 Precocious puberty
0.000 0.898 0.102
E30.0 Delayed puberty
0.000 0.898 0.102
E32.9 Disease of thymus, unspecified
0.000 0.898 0.102
E32.8 Other diseases of thymus
0.000 0.898 0.102
E32.1 Abscess of thymus
0.000 0.898 0.102
E32.0 Persistent hyperplasia of thymus
0.000 0.898 0.102
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.898 0.102
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.898 0.102
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.898 0.102
C94 Other leukaemias of specified cell type
0.000 0.899 0.101
E21.4 Other specified disorders of parathyroid gland
0.000 0.902 0.097
E34 Other endocrine disorders
0.000 0.903 0.097
K60 Fissure and fistula of anal and rectal regions
0.000 0.903 0.097
H00 Hordeolum and chalazion
0.096 0.904 0.000
E22 Hyperfunction of pituitary gland
0.000 0.905 0.095
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.905 0.095
E20.8 Other hypoparathyroidism
0.000 0.907 0.093
E20.1 Pseudohypoparathyroidism
0.000 0.907 0.093
E20.0 Idiopathic hypoparathyroidism
0.000 0.907 0.093
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.908 0.092
K60.0 Acute anal fissure
0.000 0.908 0.092
E26.9 Hyperaldosteronism, unspecified
0.000 0.909 0.091
E26.8 Other hyperaldosteronism
0.000 0.909 0.091
E26.1 Secondary hyperaldosteronism
0.000 0.909 0.091
C82.3 Follicular lymphoma grade IIIa
0.000 0.909 0.091
K60.3 Anal fistula
0.000 0.909 0.091
E51 Thiamine deficiency
0.000 0.909 0.090
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.910 0.090
E25.9 Adrenogenital disorder, unspecified
0.000 0.911 0.089
E25.8 Other adrenogenital disorders
0.000 0.911 0.089
E58 Dietary calcium deficiency
0.000 0.911 0.089
E56 Other vitamin deficiencies
0.000 0.912 0.088
L43 Lichen planus
0.087 0.913 0.001
E44.1 Mild protein-energy malnutrition
0.000 0.913 0.087
E44.0 Moderate protein-energy malnutrition
0.000 0.913 0.087
C84.0 Mycosis fungoides
0.000 0.913 0.087
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.914 0.086
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.914 0.085
E63 Other nutritional deficiencies
0.000 0.914 0.085
E50 Vitamin A deficiency
0.000 0.914 0.085
E60 Dietary zinc deficiency
0.000 0.914 0.085
E59 Dietary selenium deficiency
0.000 0.914 0.085
E52 Niacin deficiency [pellagra]
0.000 0.914 0.085
E65-E68 Obesity and other hyperalimentation
0.000 0.915 0.085
E29.8 Other testicular dysfunction
0.000 0.917 0.083
E29.0 Testicular hyperfunction
0.000 0.917 0.083
K60.5 Anorectal fistula
0.000 0.917 0.083
E61 Deficiency of other nutrient elements
0.000 0.917 0.083
C82.2 Large cell, follicular
0.000 0.919 0.081
E29.9 Testicular dysfunction, unspecified
0.000 0.919 0.081
E20.9 Hypoparathyroidism, unspecified
0.000 0.919 0.081
C84.5 Other and unspecified T-cell lymphomas
0.000 0.919 0.081
H00.0 Hordeolum and other deep inflammation of eyelid
0.081 0.919 0.000
C95.9 Leukaemia, unspecified
0.000 0.920 0.080
C62.9 Testis, unspecified
0.080 0.920 0.000
E34.8 Other specified endocrine disorders
0.000 0.921 0.079
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.921 0.079
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.921 0.078
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.921 0.078
E16.4 Abnormal secretion of gastrin
0.000 0.921 0.078
E16.3 Increased secretion of glucagon
0.000 0.921 0.078
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.921 0.078
C86.4 Blastic NK-cell lymphoma
0.000 0.921 0.078
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.921 0.078
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.921 0.078
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.921 0.078
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.921 0.078
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.922 0.078
C96.8 Histiocytic sarcoma
0.000 0.922 0.078
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.922 0.078
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.922 0.078
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.922 0.078
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.922 0.078
C96.3 True histiocytic lymphoma
0.000 0.922 0.078
C96.2 Malignant mast cell tumour
0.000 0.922 0.078
C96.1 Malignant histiocytosis
0.000 0.922 0.078
C96.0 Letterer-Siwe disease
0.000 0.922 0.078
C82.6 Cutaneous follicle centre lymphoma
0.000 0.922 0.078
C82.5 Diffuse follicle centre lymphoma
0.000 0.922 0.078
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.923 0.077
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.923 0.077
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.923 0.077
C84.3 Lymphoepithelioid lymphoma
0.000 0.923 0.077
C84.2 T-zone lymphoma
0.000 0.923 0.077
C84.1 Sezary's diease
0.000 0.923 0.077
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.923 0.077
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.923 0.077
C92.3 Myeloid sarcoma
0.000 0.923 0.077
C92.2 Subacute myeloid leukaemia
0.000 0.923 0.077
E54 Ascorbic acid deficiency
0.000 0.924 0.076
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.924 0.076
C88.7 Other malignant immunoproliferative diseases
0.000 0.924 0.076
C88.3 Immunoproliferative small intestinal disease
0.000 0.924 0.076
C88.2 Gamma heavy chain disease
0.000 0.924 0.076
C88.1 Alpha heavy chain disease
0.000 0.924 0.076
E26.0 Primary hyperaldosteronism
0.000 0.924 0.075
C93.9 Monocytic leukaemia, unspecified
0.000 0.925 0.075
C93.7 Other monocytic leukaemia
0.000 0.925 0.075
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.925 0.075
C93.2 Subacute monocytic leukaemia
0.000 0.925 0.075
C93.0 Acute monocytic leukaemia
0.000 0.925 0.075
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.925 0.075
C92.5 Acute myelomonocytic leukaemia
0.000 0.925 0.075
C95.7 Other leukaemia of unspecified cell type
0.000 0.925 0.075
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.925 0.075
E16.1 Other hypoglycaemia
0.000 0.925 0.075
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.926 0.073
E34.3 Short stature, not elsewhere classified
0.000 0.927 0.073
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.927 0.073
K60.4 Rectal fistula
0.000 0.927 0.073
C94.7 Other specified leukaemias
0.000 0.927 0.073
C94.5 Acute myelofibrosis
0.000 0.927 0.073
C94.4 Acute panmyelosis
0.000 0.927 0.073
C94.3 Mast cell leukaemia
0.000 0.927 0.073
C94.2 Acute megakaryoblastic leukaemia
0.000 0.927 0.073
C94.1 Chronic erythraemia
0.000 0.927 0.073
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.927 0.073
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.927 0.072
C93.1 Chronic monocytic leukaemia
0.000 0.929 0.071
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.929 0.071
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.929 0.070
E13.9 Without complications
0.000 0.930 0.070
E51.2 Wernicke's encephalopathy
0.000 0.930 0.070
E34.5 Androgen resistance syndrome
0.000 0.930 0.069
E34.4 Constitutional tall stature
0.000 0.930 0.069
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.930 0.069
E34.1 Other hypersecretion of intestinal hormones
0.000 0.930 0.069
C82.4 Follicular lymphoma grade IIIb
0.000 0.931 0.069
E22.8 Other hyperfunction of pituitary gland
0.000 0.931 0.068
C82.0 Small cleaved cell, follicular
0.000 0.932 0.068
C92.9 Myeloid leukaemia, unspecified
0.000 0.932 0.067
E27 Other disorders of adrenal gland
0.000 0.933 0.067
C95.0 Acute leukaemia of unspecified cell type
0.000 0.933 0.066
E56.1 Deficiency of vitamin K
0.000 0.934 0.066
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.935 0.065
E51.9 Thiamine deficiency, unspecified
0.000 0.935 0.065
E51.8 Other manifestations of thiamine deficiency
0.000 0.935 0.065
E51.1 Beriberi
0.000 0.935 0.065
E61.2 Magnesium deficiency
0.000 0.935 0.065
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.935 0.064
E56.9 Vitamin deficiency, unspecified
0.000 0.936 0.063
E56.8 Deficiency of other vitamins
0.000 0.936 0.063
E56.0 Deficiency of vitamin E
0.000 0.936 0.063
C92.4 Acute promyelocytic leukaemia
0.000 0.937 0.063
L43.3 Subacute (active) lichen planus
0.062 0.937 0.001
L43.2 Lichenoid drug reaction
0.062 0.937 0.001
L43.1 Bullous lichen planus
0.062 0.937 0.001
L43.0 Hypertrophic lichen planus
0.062 0.937 0.001
E04 Other non-toxic goitre
0.000 0.938 0.062
E50.9 Vitamin A deficiency, unspecified
0.000 0.938 0.061
E50.8 Other manifestations of vitamin A deficiency
0.000 0.938 0.061
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.938 0.061
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.938 0.061
E50.5 Vitamin A deficiency with night blindness
0.000 0.938 0.061
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.938 0.061
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.938 0.061
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.938 0.061
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.938 0.061
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.938 0.061
E63.9 Nutritional deficiency, unspecified
0.000 0.938 0.061
E63.8 Other specified nutritional deficiencies
0.000 0.938 0.061
E63.1 Imbalance of constituents of food intake
0.000 0.938 0.061
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.938 0.061
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.938 0.061
E64.8 Sequelae of other nutritional deficiencies
0.000 0.938 0.061
E64.3 Sequelae of rickets
0.000 0.938 0.061
E64.2 Sequelae of vitamin C deficiency
0.000 0.938 0.061
E64.1 Sequelae of vitamin A deficiency
0.000 0.938 0.061
E64.0 Sequelae of protein-energy malnutrition
0.000 0.938 0.061
E67 Other hyperalimentation
0.000 0.938 0.061
E68 Sequelae of hyperalimentation
0.000 0.938 0.061
E53 Deficiency of other B group vitamins
0.000 0.939 0.061
C84.4 Peripheral T-cell lymphoma
0.000 0.940 0.060
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.940 0.060
E61.9 Deficiency of nutrient element, unspecified
0.000 0.940 0.059
E61.8 Deficiency of other specified nutrient elements
0.000 0.940 0.059
E61.7 Deficiency of multiple nutrient elements
0.000 0.940 0.059
E61.6 Vanadium deficiency
0.000 0.940 0.059
E61.5 Molybdenum deficiency
0.000 0.940 0.059
E61.4 Chromium deficiency
0.000 0.940 0.059
E61.3 Manganese deficiency
0.000 0.940 0.059
E61.0 Copper deficiency
0.000 0.940 0.059
E29.1 Testicular hypofunction
0.000 0.941 0.059
C91 Lymphoid leukaemia
0.000 0.941 0.059
E55 Vitamin D deficiency
0.000 0.942 0.058
E23.0 Hypopituitarism
0.000 0.942 0.058
E22.1 Hyperprolactinaemia
0.000 0.942 0.058
C92.7 Other myeloid leukaemia
0.000 0.942 0.057
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.943 0.057
Z51.3 Blood transfusion without reported diagnosis
0.000 0.947 0.053
C83.0 Small cell (diffuse)
0.000 0.947 0.052
L43.8 Other lichen planus
0.050 0.949 0.001
E27.1 Primary adrenocortical insufficiency
0.000 0.950 0.050
C91.9 Lymphoid leukaemia, unspecified
0.000 0.950 0.050
E61.1 Iron deficiency
0.000 0.951 0.049
E27.5 Adrenomedullary hyperfunction
0.000 0.951 0.048
E27.0 Other adrenocortical overactivity
0.000 0.951 0.048
E65 Localised adiposity
0.000 0.951 0.048
K90-K93 Other diseases of the digestive system
0.000 0.952 0.048
E27.9 Disorder of adrenal gland, unspecified
0.000 0.952 0.048
E21.0 Primary hyperparathyroidism
0.000 0.953 0.047
N05.2 Diffuse membranous glomerulonephritis
0.000 0.954 0.046
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.954 0.046
N05.9 Unspecified
0.000 0.955 0.045
N05 Unspecified nephritic syndrome
0.000 0.955 0.045
E04.8 Other specified non-toxic goitre
0.000 0.955 0.044
E67.8 Other specified hyperalimentation
0.000 0.956 0.044
E67.3 Hypervitaminosis D
0.000 0.956 0.044
E67.2 Megavitamin-B6 syndrome
0.000 0.956 0.044
E67.1 Hypercarotenaemia
0.000 0.956 0.044
E67.0 Hypervitaminosis A
0.000 0.956 0.044
E53.1 Pyridoxine deficiency
0.000 0.956 0.044
E53.0 Riboflavin deficiency
0.000 0.956 0.044
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.957 0.043
M35.3 Polymyalgia rheumatica
0.000 0.957 0.043
C90 Multiple myeloma and malignant plasma cell neoplasms
0.001 0.957 0.042
C92.0 Acute myeloid leukaemia
0.000 0.958 0.042
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.958 0.042
C91.7 Other lymphoid leukaemia
0.000 0.958 0.042
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.958 0.042
C91.3 Prolymphocytic leukaemia
0.000 0.958 0.042
C91.2 Subacute lymphocytic leukaemia
0.000 0.958 0.042
C91.5 Adult T-cell leukaemia
0.000 0.958 0.042
E55.0 Rickets, active
0.000 0.958 0.042
E53.9 Vitamin B deficiency, unspecified
0.000 0.959 0.041
E22.0 Acromegaly and pituitary gigantism
0.000 0.960 0.039
E83 Disorders of mineral metabolism
0.037 0.960 0.002
E34.9 Endocrine disorder, unspecified
0.001 0.961 0.038
N05.1 Focal and segmental glomerular lesions
0.000 0.961 0.038
E04.0 Non-toxic diffuse goitre
0.000 0.962 0.038
K50.0 Crohn's disease of small intestine
0.038 0.962 0.000
E34.0 Carcinoid syndrome
0.001 0.962 0.037
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.963 0.037
E27.2 Addisonian crisis
0.000 0.964 0.036
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.965 0.035
C91.4 Hairy-cell leukaemia
0.000 0.966 0.034
C90.1 Plasma cell leukaemia
0.001 0.967 0.033
N05.6 Dense deposit disease
0.000 0.967 0.032
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.967 0.032
N05.0 Minor glomerular abnormality
0.000 0.967 0.032
K60.1 Chronic anal fissure
0.000 0.968 0.032
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.969 0.031
C91.0 Acute lymphoblastic leukaemia
0.000 0.969 0.031
C90.3 Solitary plasmacytoma
0.001 0.970 0.029
N05.7 Diffuse crescentic glomerulonephritis
0.000 0.970 0.029
E83.9 Disorder of mineral metabolism, unspecified
0.028 0.971 0.002
N05.8 Other
0.000 0.971 0.029
K50 Crohn's disease [regional enteritis]
0.029 0.971 0.000
K50.8 Other Crohn's disease
0.029 0.971 0.000
E83.8 Other disorders of mineral metabolism
0.027 0.971 0.002
E83.2 Disorders of zinc metabolism
0.027 0.971 0.002
E83.0 Disorders of copper metabolism
0.027 0.971 0.002
E27.8 Other specified disorders of adrenal gland
0.000 0.972 0.027
E53.8 Deficiency of other specified B group vitamins
0.000 0.973 0.027
E14.9 Without complications
0.000 0.975 0.025
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.975 0.025
K93.1 Megacolon in Chagas' disease
0.000 0.975 0.025
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.975 0.025
G63.2 Diabetic polyneuropathy
0.024 0.976 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.